Format
Sort by
Items per page

Send to

Choose Destination

Best matches for fracture AND osteoporosis AND preventive medicine specialty AND woman:

Search results

Items: 1 to 20 of 267

1.

Observational study of the bisphosphonate-related osteonecrosis of jaws.

Lungu AE, Lazar MA, Tonea A, Rotaru H, Roman RC, Badea ME.

Clujul Med. 2018;91(2):209-215. doi: 10.15386/cjmed-838. Epub 2018 Apr 25.

PMID:
29785160
2.

Health literacy and uptake of anti-fracture medications in a population-based sample of Australian women.

Hosking SM, Brennan-Olsen SL, Beauchamp A, Buchbinder R, Williams LJ, Pasco JA.

Res Social Adm Pharm. 2018 May 9. pii: S1551-7411(17)30828-8. doi: 10.1016/j.sapharm.2018.05.002. [Epub ahead of print]

PMID:
29778345
3.

Improved fracture prediction using different FRAX adjustments in HIV-infected women.

Yang J, Sharma A, Shi Q, Anastos K, Cohen MH, Golub ET, Gustafson D, Merenstein D, Mack WJ, Tien PC, Nieves J, Yin MT.

AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001864. [Epub ahead of print]

PMID:
29762165
4.

Association between body mass index and the risk of hip fracture by sex and age: A prospective cohort study.

Kim SH, Yi SW, Yi JJ, Kim YM, Won YJ.

J Bone Miner Res. 2018 May 11. doi: 10.1002/jbmr.3464. [Epub ahead of print]

PMID:
29750839
5.

Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld S, Mangione CM, Silverstein M, Simon MA, Tseng CW.

JAMA. 2018 Apr 17;319(15):1592-1599. doi: 10.1001/jama.2018.3185.

PMID:
29677309
6.

Low peak jump power is associated with elevated odds of dysmobility syndrome in community-dwelling elderly individuals: the Korean Urban Rural Elderly (KURE) study.

Hong N, Kim CO, Youm Y, Kim HC, Rhee Y.

Osteoporos Int. 2018 Mar 8. doi: 10.1007/s00198-018-4466-0. [Epub ahead of print]

PMID:
29520606
7.

[Experience in using Prolia in patients with postmenopausal osteoporosis in clinical practice].

Skripnikova IA, Kosmatova OV, Abirova ES, Novikov VE, Murashko LM.

Ter Arkh. 2017;89(12. Vyp. 2):190-196. doi: 10.17116/terarkh20178912190-196. Russian.

PMID:
29488480
8.

Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps.

Hsieh E, Wang Q, Zhang R, Niu X, Xia W, Fraenkel L, Insogna KL, Li J, Smith JS, Zhou C, Qiao YL, Zhang P.

BMC Cancer. 2018 Jan 30;18(1):104. doi: 10.1186/s12885-018-4014-5.

9.

Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium.

Papadimitriou N, Tsilidis KK, Orfanos P, Benetou V, Ntzani EE, Soerjomataram I, Künn-Nelen A, Pettersson-Kymmer U, Eriksson S, Brenner H, Schöttker B, Saum KU, Holleczek B, Grodstein FD, Feskanich D, Orsini N, Wolk A, Bellavia A, Wilsgaard T, Jørgensen L, Boffetta P, Trichopoulos D, Trichopoulou A.

Lancet Public Health. 2017 May;2(5):e239-e246. doi: 10.1016/S2468-2667(17)30046-4. Epub 2017 Apr 11.

10.

Preventing future fractures: effectiveness of an orthogeriatric fracture liaison service compared to an outpatient fracture liaison service and the standard management in patients with hip fracture.

Naranjo A, Fernández-Conde S, Ojeda S, Torres-Hernández L, Hernández-Carballo C, Bernardos I, Rodríguez S, Laynez P.

Arch Osteoporos. 2017 Dec 11;12(1):112. doi: 10.1007/s11657-017-0373-9.

PMID:
29230540
11.

Identification of a novel locus on chromosome 2q13, which predisposes to clinical vertebral fractures independently of bone density.

Alonso N, Estrada K, Albagha OME, Herrera L, Reppe S, Olstad OK, Gautvik KM, Ryan NM, Evans KL, Nielson CM, Hsu YH, Kiel DP, Markozannes G, Ntzani EE, Evangelou E, Feenstra B, Liu X, Melbye M, Masi L, Brandi ML, Riches P, Daroszewska A, Olmos JM, Valero C, Castillo J, Riancho JA, Husted LB, Langdahl BL, Brown MA, Duncan EL, Kaptoge S, Khaw KT, Usategui-Martín R, Del Pino-Montes J, González-Sarmiento R, Lewis JR, Prince RL, D'Amelio P, García-Giralt N, Nogués X, Mencej-Bedrac S, Marc J, Wolstein O, Eisman JA, Oei L, Medina-Gómez C, Schraut KE, Navarro P, Wilson JF, Davies G, Starr J, Deary I, Tanaka T, Ferrucci L, Gianfrancesco F, Gennari L, Lucas G, Elosua R, Uitterlinden AG, Rivadeneira F, Ralston SH.

Ann Rheum Dis. 2018 Mar;77(3):378-385. doi: 10.1136/annrheumdis-2017-212469. Epub 2017 Nov 23.

12.

Second Hip Fracture: Incidence, Trends, and Predictors.

Mazzucchelli R, Pérez-Fernández E, Crespí N, García-Vadillo A, Rodriguez Caravaca G, Gil de Miguel A, Carmona L.

Calcif Tissue Int. 2018 Jun;102(6):619-626. doi: 10.1007/s00223-017-0364-2. Epub 2017 Nov 20.

PMID:
29159516
13.

High dairy protein intake is associated with greater bone strength parameters at the distal radius and tibia in older men: a cross-sectional study.

Langsetmo L, Shikany JM, Burghardt AJ, Cawthon PM, Orwoll ES, Cauley JA, Taylor BC, Schousboe JT, Bauer DC, Vo TN, Ensrud KE; Osteoporotic Fractures in Men (MrOS) Study Research Group.

Osteoporos Int. 2018 Jan;29(1):69-77. doi: 10.1007/s00198-017-4261-3. Epub 2017 Oct 23.

PMID:
29063213
14.

Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors.

Martínez P, Galve E, Arrazubi V, Sala MÁ, Fernández S, Pérez CE, Arango JF, Torre I.

Reumatol Clin. 2017 Oct 11. pii: S1699-258X(17)30229-2. doi: 10.1016/j.reuma.2017.08.005. [Epub ahead of print] English, Spanish.

15.

Trends in osteoporotic hip fracture epidemiology over a 17-year period in a Spanish population: Alcorcón 1999-2015.

Mazzucchelli Esteban R, Pérez-Fernández E, Crespí-Villarías N, García-Vadillo A, Rodriguez-Caravaca G, Gil de Miguel A, Carmona L.

Arch Osteoporos. 2017 Sep 27;12(1):84. doi: 10.1007/s11657-017-0376-6.

PMID:
28956291
16.

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole.

Monda V, Lupoli GA, Messina G, Peluso R, Panico A, Villano I, Salerno M, Sessa F, Marciello F, Moscatelli F, Valenzano A, Molino L, Lupoli R, Fonderico F, Tortora A, Pisano A, Ruberto M, Gabriella M, Cavaliere G, Trinchese G, Mollica MP, Cipolloni L, Cibelli G, Monda M, Lupoli G, Messina A.

Front Pharmacol. 2017 Sep 12;8:632. doi: 10.3389/fphar.2017.00632. eCollection 2017.

17.

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH.

Climacteric. 2017 Oct;20(5):402-413. doi: 10.1080/13697137.2017.1362156. Epub 2017 Aug 14.

PMID:
28805475
18.

Osteoporosis Risk Calculators.

Edwards BJ.

J Clin Densitom. 2017 Jul - Sep;20(3):379-388. doi: 10.1016/j.jocd.2017.06.024. Epub 2017 Jul 22.

PMID:
28739082
19.

Current and Emerging Strategies in Osteoporosis Management.

Ivanova S, Vasileva L.

Curr Pharm Des. 2017;23(41):6279-6287. doi: 10.2174/1381612823666170714122714.

PMID:
28714404
20.

Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis.

Yoo JI, Ha YC, Won YY, Yang KH, Kim SB, Yoo JH, Kim DS.

J Bone Metab. 2017 May;24(2):91-96. doi: 10.11005/jbm.2017.24.2.91. Epub 2017 May 31.

Supplemental Content

Loading ...
Support Center